ALLMedicine™ Pineal Tumors Center
Research & Reviews 48 results
http://emedicine.medscape.com/article/249945-overview
Aug 8th, 2022 - Practice Essentials Anatomy and pathophysiology The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostr...
https://emedicine.medscape.com/article/249945-print
Aug 8th, 2022 - Practice Essentials Anatomy and pathophysiology The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostr...
https://emedicine.medscape.com/article/249945-overview
Aug 8th, 2022 - Practice Essentials Anatomy and pathophysiology The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostr...
https://doi.org/10.1007/s00381-022-05593-6
Child's Nervous System : ChNS : Official Journal of the I... Malik N, Samples DC et. al.
Jul 14th, 2022 - Pineal region tumors (PRT) represent less than 1% of brain neoplasms. The rare and heterogeneous nature of these tumors is reflected in the variety of treatment modalities employed. A single-center retrospective review of all pediatric patients wi...
https://doi.org/10.1007/s00381-021-05393-4
Child's Nervous System : ChNS : Official Journal of the I... Jung TY, Baek HJ et. al.
Nov 11th, 2021 - A mixed germ cell tumor with a teratoma component can become enlarged following chemotherapy, and such an event is diagnosed as growing teratoma syndrome. Removing large, hypervascular tumors including a tumor encased by developed vasculatures fro...
Clinicaltrials.gov 5 results
https://clinicaltrials.gov/ct2/show/NCT01182883
Jul 2nd, 2017 - Background IMC-A12 is a fully recombinant IgG1monoclonal antibody to the insulin-like growth factor receptor (IGFR). It acts as an antagonist of IGF-1 and IGF-2 ligand binding and blocks ligand binding to IGF-1R and inhibits downstream signaling o...
https://clinicaltrials.gov/ct2/show/NCT01132911
Jul 2nd, 2017 - Background: -The combination of vorinostat and bortezomib has been shown to be synergistic in vitro in a variety of malignancies, including hepatoma, multiple myeloma, leukemia, lymphoma, and gastrointestinal cancer. Currently several phase 2 adul...
https://clinicaltrials.gov/ct2/show/NCT01130623
Jul 2nd, 2017 - Background: Pazopanib is a potent and selective multi-target receptor tyrosine kinase inhibitor of vascular endothelial growth factor (VEGF) receptors (VEGFR)-1, -2, and -3, c-kit and platelet derived growth factor (PDGF) receptors-alpha and -beta...
https://clinicaltrials.gov/ct2/show/NCT00025077
Aug 2nd, 2013 - OBJECTIVES: Determine the feasibility of cyclophosphamide and surgical resection or radiotherapy followed by thiotepa, carboplatin, and autologous peripheral blood stem cell rescue in patients with recurrent medulloblastoma or supratentorial neuro...
https://clinicaltrials.gov/ct2/show/NCT00002463
Feb 18th, 2013 - OBJECTIVES: I. Determine the efficacy of high-dose methotrexate (HMTX) in combination with mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) in infants or young children with primitive neuroectodermal tumors (PNET) (including medul...
